Literature DB >> 17981502

Ubiquitin-proteasome system as a modulator of cell fate.

Simon J Thompson1, Liam T Loftus, Michelle D Ashley, Robert Meller.   

Abstract

The ubiquitin-proteasome system is the major non-lysosymal system for degrading proteins in the cell; the work leading to its discovery was awarded the Nobel Prize in Chemistry in 2004. In addition to small ubiquitin-like modifiers (e.g. Sumo and Nedd8), ubiquitin is involved in the complex regulation of the levels and function of many proteins and signaling pathways involved in determining cell fate. The cell death regulatory proteins, such as Bcl-2 family proteins and caspases are targeted for degradation by the ubiquitin proteasome system (UPS). In addition to mediating the degradation of proteins, the UPS regulates function and translocation of proteins, many of which play a role in the determination of cell fate. For example the UPS can regulate the activity of transcription factors, such as P53, NF-kappaB and HIF-1 alpha, which control the expression of protein mediators of cell death. Aberrant UPS function has been reported in multiple neuropathologies including Parkinson's diseases and ischemia. With the number of ubiquitin conjugating and de-conjugating enzymes reaching close to the levels of protein kinases and phosphatases, it is clear that ubiquitination is an important biological regulatory step for proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981502      PMCID: PMC2265078          DOI: 10.1016/j.coph.2007.09.010

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  59 in total

Review 1.  A proteasome howdunit: the case of the missing signal.

Authors:  R Verma; R J Deshaies
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Chaperone functions of the E3 ubiquitin ligase CHIP.

Authors:  Meredith F N Rosser; Erin Washburn; Paul J Muchowski; Cam Patterson; Douglas M Cyr
Journal:  J Biol Chem       Date:  2007-06-01       Impact factor: 5.157

Review 3.  Ubiquitin and ubiquitin-like proteins in protein regulation.

Authors:  Joerg Herrmann; Lilach O Lerman; Amir Lerman
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

4.  Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt.

Authors:  Matthew R Pratt; Edmund C Schwartz; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

5.  Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.

Authors:  K Breitschopf; J Haendeler; P Malchow; A M Zeiher; S Dimmeler
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Regulation of apoptosis signal-regulating kinase 1 degradation by G alpha13.

Authors:  Mikhail A Kutuzov; Alexandra V Andreeva; Tatyana A Voyno-Yasenetskaya
Journal:  FASEB J       Date:  2007-06-26       Impact factor: 5.191

7.  Transient global cerebral ischemia induces a massive increase in protein sumoylation.

Authors:  Wei Yang; Huaxin Sheng; David S Warner; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-13       Impact factor: 6.200

8.  Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.

Authors:  Monica Joch; Ariel R Ase; Carol X-Q Chen; Penny A MacDonald; Maria Kontogiannea; Amadou T Corera; Alexis Brice; Philippe Séguéla; Edward A Fon
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

9.  SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.

Authors:  Mélanie A Berta; Nathalie Mazure; Maurice Hattab; Jacques Pouysségur; M Christiane Brahimi-Horn
Journal:  Biochem Biophys Res Commun       Date:  2007-06-27       Impact factor: 3.575

10.  Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.

Authors:  Meng K Lim; Takeshi Kawamura; Yosuke Ohsawa; Masafumi Ohtsubo; Shuichi Asakawa; Atsushi Takayanagi; Nobuyoshi Shimizu
Journal:  Exp Cell Res       Date:  2007-04-20       Impact factor: 3.905

View more
  33 in total

1.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

Review 2.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

3.  Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.

Authors:  Mohammad A Shahshahan; Maureen N Beckley; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2011-08-23       Impact factor: 6.166

4.  Proteasome inhibition modulates kinase activation in neural cells: relevance to ubiquitination, ribosomes, and survival.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Annadora J Bruce-Keller; Ying Liu; Jeffrey N Keller
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

Review 5.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

6.  Presynaptic silencing is an endogenous neuroprotectant during excitotoxic insults.

Authors:  Joshua Hogins; Devon C Crawford; Xiaoping Jiang; Steven Mennerick
Journal:  Neurobiol Dis       Date:  2011-05-14       Impact factor: 5.996

Review 7.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

8.  The ubiquitin ligase Rsp5 is required for ribosome stability in Saccharomyces cerevisiae.

Authors:  Natalia Shcherbik; Dimitri G Pestov
Journal:  RNA       Date:  2011-06-10       Impact factor: 4.942

9.  Virus-induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade.

Authors:  Miguel Avia; José M Rojas; Lisa Miorin; Elena Pascual; Piet A Van Rijn; Verónica Martín; Adolfo García-Sastre; Noemí Sevilla
Journal:  EMBO Rep       Date:  2019-10-11       Impact factor: 8.807

Review 10.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.